Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Term Exenatide vs Insulin in Newly Diagnosed T2D
NCT01270191Phase 4Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Nov 2010
- Primary completion
- Dec 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Taipei Veterans General Hospital. Status: unknown.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01270191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270191.